Steven Bates image

New drug pricing plans will ‘damage UK biotech’

August 16, 2013
Research and Development, Sales and Marketing BIA, Hunt, NHS, VBP, bates, biotech

The BioIndustry Association is warning that the government’s new drug pricing scheme could put future investment in the UK’s biotech …

Boehringer to shut down Petersburg chemicals facility

August 16, 2013
Manufacturing and Production, Sales and Marketing Boehringer, Petersburg

Boehringer Ingelheim has conceded defeat in its search for a buyer for its chemicals facility in Petersburg, US, and is …

xalkori image

Price cut not enough for Pfizer’s Xalkori

August 16, 2013
Sales and Marketing NICE, Pfizer, Xalkori, lung cancer

In final draft guidance NICE has rejected Pfizer’s new lung cancer drug Xalkori because of its high cost. The Institute …

Pharmstandard buys Singapore API firm to guarantee supply

August 16, 2013
Manufacturing and Production OTC, Pharmstandard, bever

Russia’s largest drug company Pharmstandard has agreed a $590 million deal to buy the Singapore-based supplier of active pharmaceutical ingredients …

laureen_debuono

Cadence appoints Laureen DeBuono to its Board

August 16, 2013
Manufacturing and Production, Medical Communications, Research and Development DeBuono, cadence

Biopharma firm Cadence Pharmaceuticals has appointed Laureen DeBuono to its Board of directors.  “We are very pleased to welcome Ms …

Tyvber image

GSK and Roche get EU breast cancer indication

August 15, 2013
Sales and Marketing GSK, Herceptin, Roche, Tyverb, Xeloda, breast cancer

The European Commission has granted a new indication for the use of GSK’s breast cancer drug Tyverb in combination with …

Celgene image

Celgene’s multiple myeloma pill launched in UK

August 15, 2013
Sales and Marketing Celgene, Velcade, low, myeloma

Celgene’s new oral blood cancer drug pomalidomide has been launched in the UK and Ireland as a third line treatment …

ABPI image

ABPI publishes trial disclosure ‘toolkit’

August 15, 2013
Medical Communications, Sales and Marketing ABPI, EFPIA, Goldacre, transparency

The ABPI has today launched a new clinical trial disclosure toolkit to help pharma companies meet data transparency requirements.  The …

claire_thom_astellas

Astellas hires senior VP from rival Takeda

August 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Takeda, oncology

Astellas has appointed Claire Thom from fellow Japanese firm Takeda to be senior vice president of its global oncology development. …

GSK image

HIV pill Tivicay gains FDA approval

August 14, 2013
Sales and Marketing FDA, GSK, Tivicay, ViiV

ViiV and partner GlaxoSmithKline’s new HIV drug Tivicay has been shown the FDA’s green light for distribution in the US. …

Lilly image

Phoenix from the flames for Lilly cancer drug

August 14, 2013
Research and Development, Sales and Marketing NSCLC, lilly, lung cancer, necitumumab

A drug that once looked doomed to fail has shocked analysts by helping late-stage lung cancer patients live longer. Necitumumab …

anne_lindblad_emmes

New president and chief executive for EMMES

August 14, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMMES

Research support firm The EMMES Corporation has announced that its executive VP Dr Anne Lindblad has been promoted to president …

FDA image

FDA project will examine abuse-resistant formulations

August 13, 2013
Manufacturing and Production API, CDC, FDA

The FDA is seeking tenders for a research project to examine how effective tamper-resistant formulations of opioid analgesics really are …

The new NHS: a marriage of inconvenience?

August 13, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, NHS England, andy lee, market access, quarry house

As NHS England tries to squeeze more money out of the healthcare budget to pay for specialist commissioning, Andy Lee …

Rebrand for Just:: comms agency

August 13, 2013
Medical Communications Just:: Health

London-based healthcare agency Just:: Health PR has changed its name to Just:: Health Communications. The move is in response to …

Vical image

Vical melanoma drug dropped

August 13, 2013
Research and Development, Sales and Marketing Vical, allovectin, melanoma

Vical has abandoned trials of a late-stage drug for the deadliest form of skin cancer after the treatment failed to …

The Gateway to Local Adoption Series

Latest content